Antigenic potential of a highly conserved neisseria meningitidis lipopolysaccharide inner core structure defined by chemical synthesis

Chemistry and Biology

Volumn 22, Issue 1, 2015, Pages 38-49

  Reinhardt, Anika ^a,b   Yang, You ^a   Claus, Heike ^d   Pereira, Claney L ^a   Cox, Andrew D ^c   Vogel, Ulrich ^d   Anish, Chakkumkal ^a   Seeberger, Peter H ^a,b  

^a MAX PLANCK INSTITUTE OF COLLOIDS AND INTERFACES   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^d UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; EPITOPE; GLYCAN; GLYCOCONJUGATE; IMMUNOGLOBULIN G; TETRASACCHARIDE; BACTERIAL ANTIGEN; BACTERIUM ANTIBODY; LIPOPOLYSACCHARIDE; OLIGOSACCHARIDE;

ANTIBODY BLOOD LEVEL; ANTIGENICITY; ARTICLE; BACTERIAL MENINGITIS; BACTERIAL STRAIN; CONTROLLED STUDY; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; MOUSE; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL; SYNTHESIS; ANIMAL; BLOOD; CHEMISTRY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGY; METABOLISM; MICROARRAY ANALYSIS; SURFACE PLASMON RESONANCE;

BACTERIA (MICROORGANISMS); MUS; NEISSERIA MENINGITIDIS;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; HUMANS; LIPOPOLYSACCHARIDES; MICE; MICROARRAY ANALYSIS; NEISSERIA MENINGITIDIS; OLIGOSACCHARIDES; SURFACE PLASMON RESONANCE;

EID: 84921528365     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2014.11.016     Document Type: Article

References (61)

1. R. Adamo, M.R. Romano, F. Berti, R. Leuzzi, M. Tontini, E. Danieli, E. Cappelletti, O.S. Cakici, E. Swennen, and V. Pinto Phosphorylation of the synthetic hexasaccharide repeating unit is essential for the induction of antibodies to Clostridium difficile PSII cell wall polysaccharide ACS Chem. Biol. 7 2012 1420 1428
2. C. Anish, X. Guo, A. Wahlbrink, and P.H. Seeberger Plague detection by anti-carbohydrate antibodies Angew. Chem. Int. Ed. Engl. 52 2013 9524 9528
3. B.C. Baudner, V. Ronconi, D. Casini, M. Tortoli, J. Kazzaz, M. Singh, L.D. Hawkins, A. Wack, and D.T. O'Hagan MF59 emulsion is an effective delivery system for a synthetic TLR4 agonist (E6020) Pharm. Res. 26 2009 1477 1485
4. A.W. Berrington, Y.C. Tan, Y. Srikhanta, B. Kuipers, P. van der Ley, I.R. Peak, and M.P. Jennings Phase variation in meningococcal lipooligosaccharide biosynthesis genes FEMS Immunol. Med. Microbiol. 34 2002 267 275
5. J.M. Braun, J. Beuth, C.C. Blackwell, S. Giersen, P.G. Higgins, G. Tzanakaki, H. Unverhau, and D.M. Weir Neisseria meningitidis, Neisseria lactamica and Moraxella catarrhalis share cross-reactive carbohydrate antigens Vaccine 22 2004 898 908
6. M. Bröker, P.M. Dull, R. Rappuoli, and P. Costantino Chemistry of a new investigational quadrivalent meningococcal conjugate vaccine that is immunogenic at all ages Vaccine 27 2009 5574 5580
7. M. Bröker, B. Cooper, L.M. Detora, and J.J. Stoddard Critical appraisal of a quadrivalent CRM(197) conjugate vaccine against meningococcal serogroups A, C W-135 and Y (Menveo) in the context of treatment and prevention of invasive disease Infect. Drug Resist. 4 2011 137 147
8. L. Bungener, F. Geeraedts, W. Ter Veer, J. Medema, J. Wilschut, and A. Huckriede Alum boosts TH2-type antibody responses to whole-inactivated virus influenza vaccine in mice but does not confer superior protection Vaccine 26 2008 2350 2359
9. D.A. Caugant, G. Tzanakaki, and P. Kriz Lessons from meningococcal carriage studies FEMS Microbiol. Rev. 31 2007 52 63
10. B. Choudhury, C.M. Kahler, A. Datta, D.S. Stephens, and R.W. Carlson The structure of the L9 immunotype lipooligosaccharide from Neisseria meningitidis NMA Z2491 Carbohydr. Res. 343 2008 2971 2979
11. C.J. Clements, and E. Griffiths The global impact of vaccines containing aluminium adjuvants Vaccine 20 Suppl 3 2002 S24 S33
12. A.D. Cox, F. St Michael, D. Neelamegan, S. Lacelle, C.M. Cairns, M.M. Giuliani, A. Biolchi, J.C. Hoe, E.R. Moxon, and J.C. Richards Investigating the candidacy of LPS-based glycoconjugates to prevent invasive meningococcal disease: immunology of glycoconjugates with high carbohydrate loading Glycoconj. J. 27 2010 643 648
13. A.D. Cox, F. St Michael, D. Neelamegan, S. Lacelle, C. Cairns, and J.C. Richards Investigating the candidacy of LPS-based glycoconjugates to prevent invasive meningococcal disease: chemical strategies to prepare glycoconjugates with good carbohydrate loading Glycoconj. J. 27 2010 401 417
14. J. Elias, J. Findlow, R. Borrow, A. Tremmel, M. Frosch, and U. Vogel Persistence of antibodies in laboratory staff immunized with quadrivalent meningococcal polysaccharide vaccine J. Occup. Med. Toxicol. 8 2013 1 49
15. D. Evenberg, P. Hoogerhout, C.A.A. van Boeckel, G.T. Rijkers, E.C. Beuvery, J.H. van Boom, and J.T. Poolman Preparation, antigenicity, and immunogenicity of synthetic ribosylribitol phosphate oligomer-protein conjugates and their potential use for vaccination against Haemophilus influenzae type b disease J. Infect. Dis. 165 Suppl 1 1992 S152 S155
16. J. Finne, M. Leinonen, and P.H. Mäkelä Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis Lancet 2 1983 355 357
17. G. Frosi, A. Biolchi, M. Lo Sapio, F. Rigat, S. Gilchrist, J. Lucidarme, J. Findlow, R. Borrow, M. Pizza, M.M. Giuliani, and D. Medini Bactericidal antibody against a representative epidemiological meningococcal serogroup B panel confirms that MATS underestimates 4CMenB vaccine strain coverage Vaccine 31 2013 4968 4974
18. Y. Fu, M. Baumann, P. Kosma, L. Brade, and H. Brade A synthetic glycoconjugate representing the genus-specific epitope of chlamydial lipopolysaccharide exhibits the same specificity as its natural counterpart Infect. Immun. 60 1992 1314 1321
19. D.M. Granoff Review of meningococcal group B vaccines Clin. Infect. Dis. 50 Suppl 2 2010 S54 S65
20. Guo, X. (2011). Synthetic bacterial lipopolysaccharide core structures as vaccine candidates against Clamydia trachomatis and Yersinia pestis. PhD thesis (Zurich, Switzerland: ETH Zurich).
21. W.L. Hazenbos, B.M. van den Berg, J.W. van't Wout, F.R. Mooi, and R. van Furth Virulence factors determine attachment and ingestion of nonopsonized and opsonized Bordetella pertussis by human monocytes Infect. Immun. 62 1994 4818 4824
22. C.P. Hedari, R.W. Khinkarly, and G.S. Dbaibo Meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine: a new conjugate vaccine against invasive meningococcal disease Infect. Drug Resist. 7 2014 85 99
23. E. Hong, M.M. Giuliani, A.E. Deghmane, M. Comanducci, B. Brunelli, P. Dull, M. Pizza, and M.K. Taha Could the multicomponent meningococcal serogroup B vaccine (4CMenB) control Neisseria meningitidis capsular group X outbreaks in Africa? Vaccine 31 2013 1113 1116
24. K. Hubert, N. Devos, I. Mordhorst, C. Tans, G. Baudoux, C. Feron, K. Goraj, J. Tommassen, U. Vogel, J.T. Poolman, and V. Weynants ZnuD, a potential candidate for a simple and universal Neisseria meningitidis vaccine Infect. Immun. 81 2013 1915 1927
25. A. Jäkel, J.S. Plested, J.C. Hoe, K. Makepeace, M.-A.J. Gidney, S. Lacelle, F. St Michael, A.D. Cox, J.C. Richards, and E.R. Moxon Naturally-occurring human serum antibodies to inner core lipopolysaccharide epitopes of Neisseria meningitidis protect against invasive meningococcal disease caused by isolates displaying homologous inner core structures Vaccine 26 2008 6655 6663
26. M.P. Jennings, M. Bisercic, K.L.R. Dunn, M. Virji, A. Martin, K.E. Wilks, J.C. Richards, and E.R. Moxon Cloning and molecular analysis of the Isi1 (rfaF) gene of Neisseria meningitidis which encodes a heptosyl-2-transferase involved in LPS biosynthesis: evaluation of surface exposed carbohydrates in LPS mediated toxicity for human endothelial cells Microb. Pathog. 19 1995 391 407
27. C.M. Kahler, A. Datta, Y.L. Tzeng, R.W. Carlson, and D.S. Stephens Inner core assembly and structure of the lipooligosaccharide of Neisseria meningitidis: capacity of strain NMB to express all known immunotype epitopes Glycobiology 15 2005 409 419
28. G. Köhler, and C. Milstein Continuous cultures of fused cells secreting antibody of predefined specificity Nature 256 1975 495 497
29. O. Kurzai, C. Schmitt, H. Claus, U. Vogel, M. Frosch, and A. Kolb-Mäurer Carbohydrate composition of meningococcal lipopolysaccharide modulates the interaction of Neisseria meningitidis with human dendritic cells Cell. Microbiol. 7 2005 1319 1334
30. M.R. Lee, and I. Shin Facile preparation of carbohydrate microarrays by site-specific, covalent immobilization of unmodified carbohydrates on hydrazide-coated glass slides Org. Lett. 7 2005 4269 4272
31. L. Lin, A.J. Gerth, and S.L. Peng CpG DNA redirects class-switching towards "Th1-like" Ig isotype production via TLR9 and MyD88 Eur. J. Immunol. 34 2004 1483 1487
32. C.E. Martin, F. Broecker, M.A. Oberli, J. Komor, J. Mattner, C. Anish, and P.H. Seeberger Immunological evaluation of a synthetic Clostridium difficile oligosaccharide conjugate vaccine candidate and identification of a minimal epitope J. Am. Chem. Soc. 135 2013 9713 9722
33. M.D. Meeks, R. Saksena, X. Ma, T.K. Wade, R.K. Taylor, P. Kovác, and W.F. Wade Synthetic fragments of Vibrio cholerae O1 Inaba O-specific polysaccharide bound to a protein carrier are immunogenic in mice but do not induce protective antibodies Infect. Immun. 72 2004 4090 4101
34. T.E. Michaelsen, J. Kolberg, A. Aase, T.K. Herstad, and E.A. Høiby The four mouse IgG isotypes differ extensively in bactericidal and opsonophagocytic activity when reacting with the P1.16 epitope on the outer membrane PorA protein of Neisseria meningitidis Scand. J. Immunol. 59 2004 34 39
35. N. Mistretta, D. Seguin, J. Thiebaud, S. Vialle, F. Blanc, M. Brossaud, P. Talaga, G. Norheim, M. Moreau, and B. Rokbi Genetic and structural characterization of L11 lipooligosaccharide from Neisseria meningitidis serogroup A strains J. Biol. Chem. 285 2010 19874 19883
36. T.K.-K. Mong, H.-K. Lee, S.G. Durón, and C.-H. Wong Reactivity-based one-pot total synthesis of fucose GM1 oligosaccharide: a sialylated antigenic epitope of small-cell lung cancer Proc. Natl. Acad. Sci. USA 100 2003 797 802
37. S. Müller-Loennies, L. Brade, and H. Brade Neutralizing and cross-reactive antibodies against enterobacterial lipopolysaccharide Int. J. Med. Microbiol. 297 2007 321 340
38. H.P. Nguyen, N.O.L. Seto, C.R. MacKenzie, L. Brade, P. Kosma, H. Brade, and S.V. Evans Germline antibody recognition of distinct carbohydrate epitopes Nat. Struct. Biol. 10 2003 1019 1025
39. H. Nikaido Molecular basis of bacterial outer membrane permeability revisited Microbiol. Mol. Biol. Rev. 67 2003 593 656
40. C. Noti, J.L. de Paz, L. Polito, and P.H. Seeberger Preparation and use of microarrays containing synthetic heparin oligosaccharides for the rapid analysis of heparin-protein interactions Chemistry 12 2006 8664 8686
41. T. Ohara, A. Adibekian, D. Esposito, P. Stallforth, and P.H. Seeberger Towards the synthesis of a Yersinia pestis cell wall polysaccharide: enantioselective synthesis of an L-glycero-D-manno-heptose building block Chem. Commun. (Camb.) 46 2010 4106 4108
42. A. Palusiak, A. Maciejewska, C. Ługowski, and A. Rózalski The amide of galacturonic acid with lysine as an immunodominant component of the lipopolysaccharide core region from Proteus penneri 42 strain Acta Biochim. Pol. 61 2014 129 132
43. J.S. Plested, K. Makepeace, M.P. Jennings, M.A.J. Gidney, S. Lacelle, J. Brisson, A.D. Cox, A. Martin, A.G. Bird, and C.M. Tang Conservation and accessibility of an inner core lipopolysaccharide epitope of Neisseria meningitidis Infect. Immun. 67 1999 5417 5426
44. J.S. Plested, M.A.J. Gidney, P.A. Coull, H.G. Griffiths, M.A. Herbert, A.G. Bird, J.C. Richards, and E.R. Moxon Enzyme linked immunosorbent assay (ELISA) for the detection of serum antibodies to the inner core lipopolysaccharide of Neisseria meningitidis group B J. Immunol. Methods 237 2000 73 84
45. J.S. Plested, B.L. Ferry, P.A. Coull, K. Makepeace, A.K. Lehmann, F.G. MacKinnon, H.G. Griffiths, M.A. Herbert, J.C. Richards, and E.R. Moxon Functional opsonic activity of human serum antibodies to inner core lipopolysaccharide (galE) of serogroup B meningococci measured by flow cytometry Infect. Immun. 69 2001 3203 3213
46. J.S. Plested, S.L. Harris, J.C. Wright, P.A. Coull, K. Makepeace, M.-A.J. Gidney, J.-R. Brisson, J.C. Richards, D.M. Granoff, and E.R. Moxon Highly conserved Neisseria meningitidis inner-core lipopolysaccharide epitope confers protection against experimental meningococcal bacteremia J. Infect. Dis. 187 2003 1223 1234
47. V. Pozsgay, C. Chu, L. Pannell, J. Wolfe, J.B. Robbins, and R. Schneerson Protein conjugates of synthetic saccharides elicit higher levels of serum IgG lipopolysaccharide antibodies in mice than do those of the O-specific polysaccharide from Shigella dysenteriae type 1 Proc. Natl. Acad. Sci. USA 96 1999 5194 5197
48. C.R. Raetz, and C. Whitfield Lipopolysaccharide endotoxins Annu. Rev. Biochem. 71 2002 635 700
49. M.M. Rahman, C.M. Kahler, D.S. Stephens, and R.W. Carlson The structure of the lipooligosaccharide (LOS) from the α-1,2-N-acetyl glucosamine transferase (rfaK(NMB)) mutant strain CMK1 of Neisseria meningitidis: implications for LOS inner core assembly and LOS-based vaccines Glycobiology 11 2001 703 709
50. M.E. Rodríguez, W.L. Van der Pol, and J.G.J. Van de Winkel Flow cytometry-based phagocytosis assay for sensitive detection of opsonic activity of pneumococcal capsular polysaccharide antibodies in human sera J. Immunol. Methods 252 2001 33 44
51. G.F. Santos, R.R. Deck, J. Donnelly, W. Blackwelder, and D.M. Granoff Importance of complement source in measuring meningococcal bactericidal titers Clin. Diagn. Lab. Immunol. 8 2001 616 623
52. F. St Michael, E. Vinogradov, C.Q. Wenzel, B. McIntosh, J. Li, J.C. Hoe, J.C. Richards, and A.D. Cox Phosphoethanolamine is located at the 6-position and not at the 7-position of the distal heptose residue in the lipopolysaccharide from Neisseria meningitidis Glycobiology 19 2009 1436 1445
53. F. St Michael, C.M. Cairns, A.L. Filion, A. Biolchi, B. Brunelli, M. Giuliani, J.C. Richards, and A.D. Cox Investigating the candidacy of LPS-based glycoconjugates to prevent invasive meningococcal disease: conjugates based on core oligosaccharides Glycoconj. J. 31 2014 25 39
54. A.F. Verheul, A.J. Kuipers, A.K. Braat, H.A. Dekker, C.C. Peeters, H. Snippe, and J.T. Poolman Development, characterization, and biological properties of meningococcal immunotype L3,7,(8),9-specific monoclonal antibodies Clin. Diagn. Lab. Immunol. 1 1994 729 736
55. V. Weynants, P. Denoël, N. Devos, D. Janssens, C. Feron, K. Goraj, P. Momin, D. Monnom, C. Tans, and A. Vandercammen Genetically modified L3,7 and L2 lipooligosaccharides from Neisseria meningitidis serogroup B confer a broad cross-bactericidal response Infect. Immun. 77 2009 2084 2093
56. Y. Yang, C.E. Martin, and P.H. Seeberger Total synthesis of the core tetrasaccharide of Neisseria meningitidis lipopolysaccharide, a potential vaccine candidate for meningococcal diseases Chem. Sci. 3 2012 896 899
57. Y. Yang, S. Oishi, C.E. Martin, and P.H. Seeberger Diversity-oriented synthesis of inner core oligosaccharides of the lipopolysaccharide of pathogenic Gram-negative bacteria J. Am. Chem. Soc. 135 2013 6262 6271
58. B. Yu, and H. Tao Glycosyl trifluoroacetimidates. Part 1: Preparation and application as new glycosyl donors Tetrahedron Lett. 42 2001 2405 2407
59. B. Yu, and H. Tao Glycosyl trifluoroacetimidates. 2. Synthesis of dioscin and xiebai saponin I J. Org. Chem. 67 2002 9099 9102
60. P. Zhu, C.M. Tsai, and C.E. Frasch Immunologic and genetic characterization of lipooligosaccharide variants in a Neisseria meningitidis serogroup C strain FEMS Immunol. Med. Microbiol. 34 2002 193 200
61. W.D. Zollinger, and R.E. Mandrell Importance of complement source in bactericidal activity of human antibody and murine monoclonal antibody to meningococcal group B polysaccharide Infect. Immun. 40 1983 257 264